survivornet.com
Dec 15, 2024, 03:12
Kelly Shanahan: Patients considering clinical trials absolutely want the option crossover
Kelly Shanahan, Director at METAvivor Research And Support, shared a post on X:
“Patients considering clinical trials absolutely want the option crossover (ie, if you’re in the placebo and SOC arm and there is progression you can then get the experimental drug and SOC).”
More posts featuring Kelly Shanahan.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 17, 2025, 13:26
Aug 17, 2025, 13:05
Aug 17, 2025, 12:58
Aug 17, 2025, 12:42
Aug 17, 2025, 11:56
Aug 17, 2025, 11:40